Advertisement
Not a member of Pastebin yet?
Sign Up,
it unlocks many cool features!
- ---------- MESSAGE FOLLOWS ----------
- Return-Path: <setup@clearitie.com>
- Message-ID: <a7e9c28c91dce1cb6fee9ef106115ded@swift.generated>
- Date: Thu, 21 Feb 2019 02:58:24 +0000
- Subject: Certification Letter for the Study (20046) Video Training
- From: CLEARiTIE Platform <setup@clearitie.com>
- To: sara.fernandezmate@bayer.com
- MIME-Version: 1.0
- Content-Type: text/html; charset=utf-8
- Content-Transfer-Encoding: quoted-printable
- X-Peer: 127.0.0.1
- <!DOCTYPE html>
- <html lang=3D"en-US">
- <head>
- <meta charse=
- t=3D"utf-8">
- </head>
- <body>
- <!DOCTYPE html>
- <html l=
- ang=3D"en">
- <head>
- <title>Your Certification</title>
- =
- <meta charset=3D"UTF-8">
- </head>
- <body>
- =
- =20
- <div class=3D"content">
- <p>
- Sara Fernandez<b=
- r>
- =20
- 17 Jan 2019<br>
- </p>
- <p>Dear Sara Fernandez,</p>=
- <p>
- We are pleased to inform yo=
- u that you successfully completed the following
- videos fo=
- r the ESRD Study (20046) training:
- </p>
- <ul>=
- <li>1) PROTOCOL PART 1: BACKGROUND I=
- NFORMATION</li>
- <li>2) PROTOCOL PART =
- 2: STUDY PROTOCOL TRAINING</li>
- <li>3=
- ) PROTOCOL PART 3: IMPORTANT MEASUREMENTS REPORTING</li>
- =
- <li>4) STUDY DRUG SCRIPT PART 1</li>
- =
- <li>5) STUDY DRUG SCRIPT PART 2</li>
- =
- <li>6) SAFETY TRAINING DEFINITIONS</li>
- =
- <li>7) SAFETY TRAINING REPORTING</li>
- =
- <li>8) PRINCIPAL INVESTIGATOR OVERSIGHT</li>
- =
- <li>9) eCRF</li>
- =
- <li>10) IxRS</li>
- <li>11)=
- PKPD</li>
- </ul>
- =20
- =
- <p>Bayer has been informed about your successful completion.</p>
- =
- <p>Best Regards,</p>
- <p>Dr. Martin Prins</p>
- =
- </div>
- </body>
- </html>
- </body>
- </html>
- ------------ END MESSAGE ------------
- ---------- MESSAGE FOLLOWS ----------
- Return-Path: <setup@clearitie.com>
- Message-ID: <a7e9c28c91dce1cb6fee9ef106115ded@swift.generated>
- Date: Thu, 21 Feb 2019 02:58:24 +0000
- Subject: Certification Letter for the Study (20046) Video Training
- From: CLEARiTIE Platform <setup@clearitie.com>
- To: sara.fernandezmate@bayer.com
- Bcc: setup@clearitie.com
- MIME-Version: 1.0
- Content-Type: text/html; charset=utf-8
- Content-Transfer-Encoding: quoted-printable
- X-Peer: 127.0.0.1
- <!DOCTYPE html>
- <html lang=3D"en-US">
- <head>
- <meta charse=
- t=3D"utf-8">
- </head>
- <body>
- <!DOCTYPE html>
- <html l=
- ang=3D"en">
- <head>
- <title>Your Certification</title>
- =
- <meta charset=3D"UTF-8">
- </head>
- <body>
- =
- =20
- <div class=3D"content">
- <p>
- Sara Fernandez<b=
- r>
- =20
- 17 Jan 2019<br>
- </p>
- <p>Dear Sara Fernandez,</p>=
- <p>
- We are pleased to inform yo=
- u that you successfully completed the following
- videos fo=
- r the ESRD Study (20046) training:
- </p>
- <ul>=
- <li>1) PROTOCOL PART 1: BACKGROUND I=
- NFORMATION</li>
- <li>2) PROTOCOL PART =
- 2: STUDY PROTOCOL TRAINING</li>
- <li>3=
- ) PROTOCOL PART 3: IMPORTANT MEASUREMENTS REPORTING</li>
- =
- <li>4) STUDY DRUG SCRIPT PART 1</li>
- =
- <li>5) STUDY DRUG SCRIPT PART 2</li>
- =
- <li>6) SAFETY TRAINING DEFINITIONS</li>
- =
- <li>7) SAFETY TRAINING REPORTING</li>
- =
- <li>8) PRINCIPAL INVESTIGATOR OVERSIGHT</li>
- =
- <li>9) eCRF</li>
- =
- <li>10) IxRS</li>
- <li>11)=
- PKPD</li>
- </ul>
- =20
- =
- <p>Bayer has been informed about your successful completion.</p>
- =
- <p>Best Regards,</p>
- <p>Dr. Martin Prins</p>
- =
- </div>
- </body>
- </html>
- </body>
- </html>
- ------------ END MESSAGE ------------
- ---------- MESSAGE FOLLOWS ----------
- Return-Path: <setup@clearitie.com>
- Message-ID: <1edba94192af43fc080a8f9370b3e44d@swift.generated>
- Date: Thu, 21 Feb 2019 02:58:24 +0000
- Subject: Certification Letter for the Study (20046) Video Training
- From: CLEARiTIE Platform <setup@clearitie.com>
- To: nicole.blakley.ext@bayer.com
- MIME-Version: 1.0
- Content-Type: text/html; charset=utf-8
- Content-Transfer-Encoding: quoted-printable
- X-Peer: 127.0.0.1
- <!DOCTYPE html>
- <html lang=3D"en-US">
- <head>
- <meta charse=
- t=3D"utf-8">
- </head>
- <body>
- <!DOCTYPE html>
- <html l=
- ang=3D"en">
- <head>
- <title>Your Certification</title>
- =
- <meta charset=3D"UTF-8">
- </head>
- <body>
- =
- =20
- <div class=3D"content">
- <p>
- Nicole Blakley<b=
- r>
- =20
- 12 Feb 2019<br>
- </p>
- <p>Dear Nicole Blakley,</p>=
- <p>
- We are pleased to inform yo=
- u that you successfully completed the following
- videos fo=
- r the ESRD Study (20046) training:
- </p>
- <ul>=
- <li>1) PROTOCOL PART 1: BACKGROUND I=
- NFORMATION</li>
- <li>2) PROTOCOL PART =
- 2: STUDY PROTOCOL TRAINING</li>
- <li>3=
- ) PROTOCOL PART 3: IMPORTANT MEASUREMENTS REPORTING</li>
- =
- <li>4) STUDY DRUG SCRIPT PART 1</li>
- =
- <li>5) STUDY DRUG SCRIPT PART 2</li>
- =
- <li>6) SAFETY TRAINING DEFINITIONS</li>
- =
- <li>7) SAFETY TRAINING REPORTING</li>
- =
- <li>8) PRINCIPAL INVESTIGATOR OVERSIGHT</li>
- =
- <li>9) eCRF</li>
- =
- <li>10) IxRS</li>
- <li>11)=
- PKPD</li>
- </ul>
- =20
- =
- <p>Bayer has been informed about your successful completion.</p>
- =
- <p>Best Regards,</p>
- <p>Dr. Martin Prins</p>
- =
- </div>
- </body>
- </html>
- </body>
- </html>
- ------------ END MESSAGE ------------
- ---------- MESSAGE FOLLOWS ----------
- Return-Path: <setup@clearitie.com>
- Message-ID: <1edba94192af43fc080a8f9370b3e44d@swift.generated>
- Date: Thu, 21 Feb 2019 02:58:24 +0000
- Subject: Certification Letter for the Study (20046) Video Training
- From: CLEARiTIE Platform <setup@clearitie.com>
- To: nicole.blakley.ext@bayer.com
- Bcc: setup@clearitie.com
- MIME-Version: 1.0
- Content-Type: text/html; charset=utf-8
- Content-Transfer-Encoding: quoted-printable
- X-Peer: 127.0.0.1
- <!DOCTYPE html>
- <html lang=3D"en-US">
- <head>
- <meta charse=
- t=3D"utf-8">
- </head>
- <body>
- <!DOCTYPE html>
- <html l=
- ang=3D"en">
- <head>
- <title>Your Certification</title>
- =
- <meta charset=3D"UTF-8">
- </head>
- <body>
- =
- =20
- <div class=3D"content">
- <p>
- Nicole Blakley<b=
- r>
- =20
- 12 Feb 2019<br>
- </p>
- <p>Dear Nicole Blakley,</p>=
- <p>
- We are pleased to inform yo=
- u that you successfully completed the following
- videos fo=
- r the ESRD Study (20046) training:
- </p>
- <ul>=
- <li>1) PROTOCOL PART 1: BACKGROUND I=
- NFORMATION</li>
- <li>2) PROTOCOL PART =
- 2: STUDY PROTOCOL TRAINING</li>
- <li>3=
- ) PROTOCOL PART 3: IMPORTANT MEASUREMENTS REPORTING</li>
- =
- <li>4) STUDY DRUG SCRIPT PART 1</li>
- =
- <li>5) STUDY DRUG SCRIPT PART 2</li>
- =
- <li>6) SAFETY TRAINING DEFINITIONS</li>
- =
- <li>7) SAFETY TRAINING REPORTING</li>
- =
- <li>8) PRINCIPAL INVESTIGATOR OVERSIGHT</li>
- =
- <li>9) eCRF</li>
- =
- <li>10) IxRS</li>
- <li>11)=
- PKPD</li>
- </ul>
- =20
- =
- <p>Bayer has been informed about your successful completion.</p>
- =
- <p>Best Regards,</p>
- <p>Dr. Martin Prins</p>
- =
- </div>
- </body>
- </html>
- </body>
- </html>
- ------------ END MESSAGE ------------
- ---------- MESSAGE FOLLOWS ----------
- Return-Path: <setup@clearitie.com>
- Message-ID: <7e2d6de9ba94da426227b61747e9cf0e@swift.generated>
- Date: Thu, 21 Feb 2019 02:58:24 +0000
- Subject: Certification Letter for the Study (20046) Video Training
- From: CLEARiTIE Platform <setup@clearitie.com>
- To: maggie.faries@bayer.com
- MIME-Version: 1.0
- Content-Type: text/html; charset=utf-8
- Content-Transfer-Encoding: quoted-printable
- X-Peer: 127.0.0.1
- <!DOCTYPE html>
- <html lang=3D"en-US">
- <head>
- <meta charse=
- t=3D"utf-8">
- </head>
- <body>
- <!DOCTYPE html>
- <html l=
- ang=3D"en">
- <head>
- <title>Your Certification</title>
- =
- <meta charset=3D"UTF-8">
- </head>
- <body>
- =
- =20
- <div class=3D"content">
- <p>
- Maggie Faires<br=
- >
- =20
- 19 Feb 2019<br>
- </p>
- <p>Dear Maggie Faires,</p>
- =
- <p>
- We are pleased to inform you t=
- hat you successfully completed the following
- videos for t=
- he ESRD Study (20046) training:
- </p>
- <ul>
- =
- <li>1) PROTOCOL PART 1: BACKGROUND INFO=
- RMATION</li>
- <li>2) PROTOCOL PART 2: =
- STUDY PROTOCOL TRAINING</li>
- <li>3) P=
- ROTOCOL PART 3: IMPORTANT MEASUREMENTS REPORTING</li>
- =
- <li>4) STUDY DRUG SCRIPT PART 1</li>
- =
- <li>5) STUDY DRUG SCRIPT PART 2</li>
- =
- <li>6) SAFETY TRAINING DEFINITIONS</li>
- =
- <li>7) SAFETY TRAINING REPORTING</li>
- =
- <li>8) PRINCIPAL INVESTIGATOR OVERSIGHT</li>
- =
- <li>9) eCRF</li>
- =
- <li>10) IxRS</li>
- <li>11) PK=
- PD</li>
- </ul>
- =20
- =
- <p>Bayer has been informed about your successful completion.</p>
- =
- <p>Best Regards,</p>
- <p>Dr. Martin Prins</p>
- </d=
- iv>
- </body>
- </html>
- </body>
- </html>
- ------------ END MESSAGE ------------
- ---------- MESSAGE FOLLOWS ----------
- Return-Path: <setup@clearitie.com>
- Message-ID: <7e2d6de9ba94da426227b61747e9cf0e@swift.generated>
- Date: Thu, 21 Feb 2019 02:58:24 +0000
- Subject: Certification Letter for the Study (20046) Video Training
- From: CLEARiTIE Platform <setup@clearitie.com>
- To: maggie.faries@bayer.com
- Bcc: setup@clearitie.com
- MIME-Version: 1.0
- Content-Type: text/html; charset=utf-8
- Content-Transfer-Encoding: quoted-printable
- X-Peer: 127.0.0.1
- <!DOCTYPE html>
- <html lang=3D"en-US">
- <head>
- <meta charse=
- t=3D"utf-8">
- </head>
- <body>
- <!DOCTYPE html>
- <html l=
- ang=3D"en">
- <head>
- <title>Your Certification</title>
- =
- <meta charset=3D"UTF-8">
- </head>
- <body>
- =
- =20
- <div class=3D"content">
- <p>
- Maggie Faires<br=
- >
- =20
- 19 Feb 2019<br>
- </p>
- <p>Dear Maggie Faires,</p>
- =
- <p>
- We are pleased to inform you t=
- hat you successfully completed the following
- videos for t=
- he ESRD Study (20046) training:
- </p>
- <ul>
- =
- <li>1) PROTOCOL PART 1: BACKGROUND INFO=
- RMATION</li>
- <li>2) PROTOCOL PART 2: =
- STUDY PROTOCOL TRAINING</li>
- <li>3) P=
- ROTOCOL PART 3: IMPORTANT MEASUREMENTS REPORTING</li>
- =
- <li>4) STUDY DRUG SCRIPT PART 1</li>
- =
- <li>5) STUDY DRUG SCRIPT PART 2</li>
- =
- <li>6) SAFETY TRAINING DEFINITIONS</li>
- =
- <li>7) SAFETY TRAINING REPORTING</li>
- =
- <li>8) PRINCIPAL INVESTIGATOR OVERSIGHT</li>
- =
- <li>9) eCRF</li>
- =
- <li>10) IxRS</li>
- <li>11) PK=
- PD</li>
- </ul>
- =20
- =
- <p>Bayer has been informed about your successful completion.</p>
- =
- <p>Best Regards,</p>
- <p>Dr. Martin Prins</p>
- </d=
- iv>
- </body>
- </html>
- </body>
- </html>
- ------------ END MESSAGE ------------
- ---------- MESSAGE FOLLOWS ----------
- Return-Path: <setup@clearitie.com>
- Message-ID: <e66125abeed2caec75a6d831005958dc@swift.generated>
- Date: Thu, 21 Feb 2019 02:58:24 +0000
- Subject: Certification Letter for the Study (20046) Video Training
- From: CLEARiTIE Platform <setup@clearitie.com>
- To: christopher.caira@bayer.com
- MIME-Version: 1.0
- Content-Type: text/html; charset=utf-8
- Content-Transfer-Encoding: quoted-printable
- X-Peer: 127.0.0.1
- <!DOCTYPE html>
- <html lang=3D"en-US">
- <head>
- <meta charse=
- t=3D"utf-8">
- </head>
- <body>
- <!DOCTYPE html>
- <html l=
- ang=3D"en">
- <head>
- <title>Your Certification</title>
- =
- <meta charset=3D"UTF-8">
- </head>
- <body>
- =
- =20
- <div class=3D"content">
- <p>
- Christopher Cair=
- a<br>
- =20
- 17 Jan 2019<br>
- </p>
- <p>Dear Christopher Caira=
- ,</p>
- <p>
- We are pleased to info=
- rm you that you successfully completed the following
- vide=
- os for the ESRD Study (20046) training:
- </p>
- =
- <ul>
- <li>1) PROTOCOL PART 1: BACKGRO=
- UND INFORMATION</li>
- <li>2) PROTOCOL =
- PART 2: STUDY PROTOCOL TRAINING</li>
- =
- <li>3) PROTOCOL PART 3: IMPORTANT MEASUREMENTS REPORTING</li>
- =
- <li>4) STUDY DRUG SCRIPT PART 1</li>
- =
- <li>5) STUDY DRUG SCRIPT PART 2</li>
- =
- <li>6) SAFETY TRAINING DEFINITIONS</li>
- =
- <li>7) SAFETY TRAINING REPORTING</li>
- =
- <li>8) PRINCIPAL INVESTIGATOR OVERSIGHT</li>=
- <li>9) eCRF</li>
- =
- <li>10) IxRS</li>
- =
- <li>11) PKPD</li>
- </ul>
- =
- =20
- <p>Bayer has been informed about your successful completion.=
- </p>
- <p>Best Regards,</p>
- <p>Dr. Martin Prins</p>
- =
- </div>
- </body>
- </html>
- </body>
- </html>
- ------------ END MESSAGE ------------
- ---------- MESSAGE FOLLOWS ----------
- Return-Path: <setup@clearitie.com>
- Message-ID: <e66125abeed2caec75a6d831005958dc@swift.generated>
- Date: Thu, 21 Feb 2019 02:58:24 +0000
- Subject: Certification Letter for the Study (20046) Video Training
- From: CLEARiTIE Platform <setup@clearitie.com>
- To: christopher.caira@bayer.com
- Bcc: setup@clearitie.com
- MIME-Version: 1.0
- Content-Type: text/html; charset=utf-8
- Content-Transfer-Encoding: quoted-printable
- X-Peer: 127.0.0.1
- <!DOCTYPE html>
- <html lang=3D"en-US">
- <head>
- <meta charse=
- t=3D"utf-8">
- </head>
- <body>
- <!DOCTYPE html>
- <html l=
- ang=3D"en">
- <head>
- <title>Your Certification</title>
- =
- <meta charset=3D"UTF-8">
- </head>
- <body>
- =
- =20
- <div class=3D"content">
- <p>
- Christopher Cair=
- a<br>
- =20
- 17 Jan 2019<br>
- </p>
- <p>Dear Christopher Caira=
- ,</p>
- <p>
- We are pleased to info=
- rm you that you successfully completed the following
- vide=
- os for the ESRD Study (20046) training:
- </p>
- =
- <ul>
- <li>1) PROTOCOL PART 1: BACKGRO=
- UND INFORMATION</li>
- <li>2) PROTOCOL =
- PART 2: STUDY PROTOCOL TRAINING</li>
- =
- <li>3) PROTOCOL PART 3: IMPORTANT MEASUREMENTS REPORTING</li>
- =
- <li>4) STUDY DRUG SCRIPT PART 1</li>
- =
- <li>5) STUDY DRUG SCRIPT PART 2</li>
- =
- <li>6) SAFETY TRAINING DEFINITIONS</li>
- =
- <li>7) SAFETY TRAINING REPORTING</li>
- =
- <li>8) PRINCIPAL INVESTIGATOR OVERSIGHT</li>=
- <li>9) eCRF</li>
- =
- <li>10) IxRS</li>
- =
- <li>11) PKPD</li>
- </ul>
- =
- =20
- <p>Bayer has been informed about your successful completion.=
- </p>
- <p>Best Regards,</p>
- <p>Dr. Martin Prins</p>
- =
- </div>
- </body>
- </html>
- </body>
- </html>
- ------------ END MESSAGE ------------
- ---------- MESSAGE FOLLOWS ----------
- Return-Path: <setup@clearitie.com>
- Message-ID: <3febe0b9aab82ee4a17f248af2b947b4@swift.generated>
- Date: Thu, 21 Feb 2019 02:58:24 +0000
- Subject: Certification Letter for the Study (20046) Video Training
- From: CLEARiTIE Platform <setup@clearitie.com>
- To: esther.munozpuig@bayer.com
- MIME-Version: 1.0
- Content-Type: text/html; charset=utf-8
- Content-Transfer-Encoding: quoted-printable
- X-Peer: 127.0.0.1
- <!DOCTYPE html>
- <html lang=3D"en-US">
- <head>
- <meta charse=
- t=3D"utf-8">
- </head>
- <body>
- <!DOCTYPE html>
- <html l=
- ang=3D"en">
- <head>
- <title>Your Certification</title>
- =
- <meta charset=3D"UTF-8">
- </head>
- <body>
- =
- =20
- <div class=3D"content">
- <p>
- Esther Mu=C3=
- =B1oz<br>
- =20
- 01 Feb 2019<br>
- </p>
- <p>Dear Esther Mu=
- =C3=B1oz,</p>
- <p>
- We are pleased=
- to inform you that you successfully completed the following
- =
- videos for the ESRD Study (20046) training:
- </p>
- =
- <ul>
- <li>1) PROTOCOL PART 1:=
- BACKGROUND INFORMATION</li>
- <li>2) P=
- ROTOCOL PART 2: STUDY PROTOCOL TRAINING</li>
- =
- <li>3) PROTOCOL PART 3: IMPORTANT MEASUREMENTS REPORTING</li>
- =
- <li>4) STUDY DRUG SCRIPT PART 1</li>
- =
- <li>5) STUDY DRUG SCRIPT PART 2</li>
- =
- <li>6) SAFETY TRAINING DEFINITIONS</li>
- =
- <li>7) SAFETY TRAINING REPORTING</li>=
- <li>8) PRINCIPAL INVESTIGATOR OVERSI=
- GHT</li>
- <li>9) eCRF</li>
- =
- <li>10) IxRS</li>
- =
- <li>11) PKPD</li>
- </ul>
- =
- =20
- <p>Bayer has been informed about your successful com=
- pletion.</p>
- <p>Best Regards,</p>
- <p>Dr. Martin Prins</p>
- =
- </div>
- </body>
- </html>
- </body>
- </ht=
- ml>
- ------------ END MESSAGE ------------
- ---------- MESSAGE FOLLOWS ----------
- Return-Path: <setup@clearitie.com>
- Message-ID: <3febe0b9aab82ee4a17f248af2b947b4@swift.generated>
- Date: Thu, 21 Feb 2019 02:58:24 +0000
- Subject: Certification Letter for the Study (20046) Video Training
- From: CLEARiTIE Platform <setup@clearitie.com>
- To: esther.munozpuig@bayer.com
- Bcc: setup@clearitie.com
- MIME-Version: 1.0
- Content-Type: text/html; charset=utf-8
- Content-Transfer-Encoding: quoted-printable
- X-Peer: 127.0.0.1
- <!DOCTYPE html>
- <html lang=3D"en-US">
- <head>
- <meta charse=
- t=3D"utf-8">
- </head>
- <body>
- <!DOCTYPE html>
- <html l=
- ang=3D"en">
- <head>
- <title>Your Certification</title>
- =
- <meta charset=3D"UTF-8">
- </head>
- <body>
- =
- =20
- <div class=3D"content">
- <p>
- Esther Mu=C3=
- =B1oz<br>
- =20
- 01 Feb 2019<br>
- </p>
- <p>Dear Esther Mu=
- =C3=B1oz,</p>
- <p>
- We are pleased=
- to inform you that you successfully completed the following
- =
- videos for the ESRD Study (20046) training:
- </p>
- =
- <ul>
- <li>1) PROTOCOL PART 1:=
- BACKGROUND INFORMATION</li>
- <li>2) P=
- ROTOCOL PART 2: STUDY PROTOCOL TRAINING</li>
- =
- <li>3) PROTOCOL PART 3: IMPORTANT MEASUREMENTS REPORTING</li>
- =
- <li>4) STUDY DRUG SCRIPT PART 1</li>
- =
- <li>5) STUDY DRUG SCRIPT PART 2</li>
- =
- <li>6) SAFETY TRAINING DEFINITIONS</li>
- =
- <li>7) SAFETY TRAINING REPORTING</li>=
- <li>8) PRINCIPAL INVESTIGATOR OVERSI=
- GHT</li>
- <li>9) eCRF</li>
- =
- <li>10) IxRS</li>
- =
- <li>11) PKPD</li>
- </ul>
- =
- =20
- <p>Bayer has been informed about your successful com=
- pletion.</p>
- <p>Best Regards,</p>
- <p>Dr. Martin Prins</p>
- =
- </div>
- </body>
- </html>
- </body>
- </ht=
- ml>
- ------------ END MESSAGE ------------
Advertisement
Add Comment
Please, Sign In to add comment
Advertisement